Replies to post #34542 on Innovation Pharmaceuticals Inc (IPIX)

[CommonRookie]

Low volume has consistently preceded big jumps in SP with CTIX. Look at the one year chart and you'll see that prior to every big jump there was a short period of extremely low volume. Obviously that could be well timed PRs or just the standard drift of interest and SP between announcements. I don't think there is anything to be learned here but what I find interesting is that the low volume appears to have come much quicker than in the past. Perhaps these stronger hands will give us a firmer floor here around 1.80 while we wait for news as opposed to dropping back to 1.50-1.60 as we did in the lag prior to ASCO. Just thinking out loud.

[petemantx]

Right now this is just not a great trading stock so quite a few of those investors have left the building. Most remaining investors, though realizing some good news may come at any time from various fronts, also understand there may be a lull in Kevetrin trial data and Prurisol results for a number of weeks and are content to sit on their shares and ride out whatever happens until the 4th qtr or early 2014.

I think the slow volume is a tremendous show of strength by long term holders because everyone knows there are plenty of bids in, quite a few in fact by the aforesaid long term holders, by those hoping to score more shares at bargain basement prices. This is understandable and I wish them all the best, but it also shows nobody currently holding said shares is playing the game of selling shares now to buy back in later at a reduced cost. Could work but could also bite you in the keister.

I had posted earlier I couldn't think of another stock with the reward/risk potential of this one and a poster responded with a stock he thought qualified for my challenge. I looked into it and bought a little starting position and told him I would look at both in about 18 months and see who really had the gem. The ironic twist of the whole matter is that CTIX is spearheading the fight against cancer and the other company has patented all the genes in tobacco that form nicotine and can now genetically grow tobacco that has next to no nicotine (1/2 mg per cigarette) up to as much nicotine as you want per cigarette (these are called premium cigarettes). So on the one hand I am invested in a company whose product is known to advance various cancers and the other company in which I am invested is curing cancer.